- Recent Funding
- Investors
- CE Ventures
CE Ventures (CEIIF) portfolio
CE Ventures (CEIIF) has 7 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It led 2 of the 6 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (2) and Robotics and hardware (2). It has co-invested with Eli Lilly, Mission BioCapital and Global Brain Corporation.
About CE Ventures
What CE Ventures invests in
- Health and bio · 2 · 29%
- Robotics and hardware · 2 · 29%
- Logistics and mobility · 2 · 29%
- Data and analytics · 2 · 29%
- Developer tools and cloud · 2 · 29%
- Manufacturing and industrial · 1 · 14%
- Commerce and retail · 1 · 14%
- Consumer and social · 1 · 14%
CE Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $60M | Global Brain Corporation, 4BIO Capital (lead), Eli Lilly +5 | ||
| Series A · $7.7M · lead | Jungle Ventures (lead), Rubamin, Mayank Singhal +1 | ||
| Series B+ · $10M | DFF Ventures, tali ventures (lead) | ||
| Series A · $38M | OMX Ventures (lead), Angelini Ventures, Mike Jafar Family Office +4 | ||
| Series B+ · lead | none named | ||
| Series B+ · $30M | Expon Capital, Western Digital Capital, Viola Ventures +4 |
How CE Ventures invests
CE Ventures portfolio companies
OOyster Therapeutics$60MSeries A · Nov 2026
DDistil$7.7MSeries A · Sep 2025
NNorthLadder$10MSeries B+ · Nov 2024
FFreya Biosciences$38MSeries A · Dec 2023
SServifySeries B+ · Apr 2023
PPliops$30MSeries B+ · Jan 2019
PPanoplybacker
| Company | Round with CE Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $60M | $60M | Nov 10, 2026 Series A |
Robotics and hardware |
Series A · $7.7M · lead | $10.8M | Sep 23, 2025 Series A |
Commerce and retail |
Series B+ · $10M | $20M | Nov 4, 2024 Series B+ |
Health and bio |
Series A · $38M | $38M | Nov 19, 2024 Series A |
Consumer and social |
Series B+ · lead | $122.1M | Jan 16, 2026 Series B+ |
Robotics and hardware |
Series B+ · $30M | $195M | Aug 16, 2022 Series B+ |
Data and analytics |
backer | undisclosed | — |
Most frequent co-investors
EEli Lilly1 shared round · last Nov 10, 2026
MMission BioCapital1 shared round · last Nov 10, 2026
GGlobal Brain Corporation1 shared round · last Nov 10, 2026
OOxford Science Enterprises1 shared round · last Nov 10, 2026
MMass General Brigham Ventures1 shared round · last Nov 10, 2026
SSyncona Partners LLP1 shared round · last Nov 10, 2026
44BIO Capital1 shared round · last Nov 10, 2026
AActium Group1 shared round · last Nov 10, 2026IIndia Quotient1 shared round · last Sep 23, 2025
JJungle Ventures1 shared round · last Sep 23, 2025
RRubamin1 shared round · last Sep 23, 2025
MMayank Singhal1 shared round · last Sep 23, 2025
Similar investors
AAngular Ventures7 companies · 4 deals in 12 mo
BBlue Cloud Ventures8 companies · 3 deals in 12 mo
IIA Ventures8 companies · 3 deals in 12 mo
FFifth Down Capital6 companies · 3 deals in 12 mo
AAraya Ventures5 companies · 4 deals in 12 moCCervin Ventures5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 6 rounds on Recent Funding that name CE Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists CE Ventures, which is a subset of its real portfolio. API: /api/v1/investors/ce-ventures (get a free API key). More: the most active VC firms and new venture capital funds.